Activation de caspases et formation de dégénérescences neurofibrillaires dans un modèle murin de la maladie d'Alzheimer

Medecine/Sciences

Volumn 26, Issue 10, 2010, Pages 787-816

  Calignon, Alix De ^a   Spires Jones, Tara L ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE;

ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; DISEASE MODEL; ENZYME ACTIVATION; ENZYMOLOGY; HIPPOCAMPUS; METABOLISM; MOUSE; NERVE DEGENERATION; NOTE; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; CASPASES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HIPPOCAMPUS; MICE; NERVE DEGENERATION;

EID: 78650238276     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20102610787     Document Type: Article

References (14)

1. Duyckaerts C, Hauw JJ. Diagnosis and staging of Alzheimer disease. Neurobiol Aging 1997;18 (suppl 4): S33-42.
2. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-6.
3. Hutton M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 2001; 56 (suppl 4): S21-5.
4. Gomez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Ann Neurol 1997; 41: 17-24.
5. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s disease. Acta Neuropathol 2002; 103: 26-35.
6. Rohn TT, Head E, Nesse WH, et al. Activation of caspase-8 in the Alzheimer’s disease brain. Neurobiol Dis 2001; 8: 1006-16.
7. Guo H, Albrecht S, Bourdeau M, et al. Active caspase-6 and caspase-6-cleaved tau in neurophil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer’s disease. Am J Pathol 2004; 165: 523-31.
8. Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005; 309: 476-81.
9. Bacskai BJ, Kajdasz ST, Christie RH, et al. Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med 2001; 7: 369-72.
10. Guntern R, Bouras C, Hof PR, Vallet PG. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer’s disease. Experientia 1992; 48: 8-10.
11. Spires-Jones TL, de Calignon A, Matsui T, et al. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J Neurosci 2008; 28: 862-7.
12. De Calignon A, Spires-Jones TL, Pitstick R, et al. Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy.J Neuropathol Exp Neurol 2009; 68: 757-61.
13. De Calignon A, Fox LM, Pitstick R, et al. Caspase activation precedes and leads to tangles. Nature 2010; 464: 1201-4.
14. Clavaguera F, Goedert M, Tolnay M. Induction et propagation de la pathologie par la protéine tau chez un modèle murin de la maladie d’Alzheimer. Med Sci (Paris) 2010; 26: 121-4.